{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:12Z","timestamp":1791576132267,"version":"4.3.4"},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T00:00:00Z","timestamp":1212105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Pancreatitis is a potentially severe condition. Patients with inflammatory bowel disease (IBD) seem to be at increased risk for acute pancreatitis.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To describe the incidence, main causes and possible predictive factors of acute pancreatitis in inflammatory bowel disease.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Information was retrospectively extracted from the clinical records of patients followed in the IBD Units of nine hospitals in Madrid (<jats:italic>n<\/jats:italic>\u2003=\u20035073).<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> A total of 82 acute pancreatitis episodes were diagnosed (cumulative incidence, 1.6%); 98% of them were mild. Recurrent acute pancreatitis developed in 13% of patients. Most cases of acute pancreatitis (63.4%) were attributed to drug exposure [azathioprine\/mercaptopurine (AZA\/MP) <jats:italic>n<\/jats:italic>\u2003=\u200346, mesalazine (mesalamine) <jats:italic>n<\/jats:italic>\u2003=\u20036]; 20.7% were idiopathic, and 12.2% were biliary. Incidence of acute pancreatitis in patients treated with AZA\/MP was 3.1%. In patients with acute pancreatitis, female gender (OR 3.4 95% CI: 1.3\u20139.3; <jats:italic>P<\/jats:italic>\u2003=\u20030.012) and Crohn\u2019s disease (CD) (OR 5.8 95% CI: 1.6\u201320.6; <jats:italic>P<\/jats:italic>\u2003=\u20030.007) were risk factors for AZA\/MP\u2010associated acute pancreatitis, the latter also when analysed only in patients treated with AZA\/MP (<jats:italic>n<\/jats:italic>\u2003=\u20031477) (OR 5.2 95% CI: 1.8\u201314; <jats:italic>P<\/jats:italic>\u2003=\u20030.002).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The incidence of acute pancreatitis in our IBD patients (1.6%) is similar to that previously described. Drugs, mainly AZA\/MP, are the leading cause. AZA\u2010induced acute pancreatitis is always mild. Patients with CD are at a higher risk for AZA\/MP\u2010associated acute pancreatitis. The frequency of idiopathic acute pancreatitis is higher than expected, suggesting that part of these cases could be extraintestinal manifestations of IBD.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2008.03746.x","type":"journal-article","created":{"date-parts":[[2008,10,13]],"date-time":"2008-10-13T12:17:34Z","timestamp":1223900254000},"page":"623-628","source":"Crossref","is-referenced-by-count":121,"title":["Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine\u2010induced pancreatitis"],"prefix":"10.1111","volume":"28","author":[{"given":"F.","family":"BERMEJO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"LOPEZ\u2010SANROMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"TAXONERA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"GISBERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"P\u00c9REZ\u2010CALLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"VERA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"MENCH\u00c9N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"MART\u00cdN\u2010ARRANZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"OPIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"CARNEROS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"VAN\u2010DOMSELAAR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"MENDOZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"LUNA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"L\u00d3PEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"CALVO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"ALGABA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.2004.057026","article-title":"UK Guidelines for the management of acute pancreatitis","volume":"54","author":"UK Working Party on Acute Pancreatitis","year":"2005","journal-title":"Gut"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365529950173096"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0471-4"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1385\/IJGC:27:3:171"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091339"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00856.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.174.2.2296641"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/269076"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199312000-00004"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01015.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-19636"},{"key":"e_1_2_6_13_2","first-page":"804","article-title":"Acute pancreatitis as a complication of Crohn\u2019s disease","volume":"84","author":"Matsumoto T","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000186485.30623.ad"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296730"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-8-641"},{"key":"e_1_2_6_17_2","first-page":"CD000545","article-title":"Azathioprine or 6\u2010mercaptopurine for inducing remission of Crohn\u2019s disease","volume":"2","author":"Sandborn W","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_18_2","first-page":"769","article-title":"Adverse effects of azathioprine in the treatment of inflammatory boweldisease","volume":"93","author":"Mart\u00ednez F","year":"2001","journal-title":"Rev Esp Enferm Dig"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0210-5705(02)70275-6"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i45.7332"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1572-0241.2003.07459.x","article-title":"Risk of acute pancreatitis in users of azathioprine: a population\u2010based case\u2013control study","volume":"98","author":"Floyd A","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.92264000.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.04123.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.4.536"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02197.x"},{"key":"e_1_2_6_26_2","first-page":"2302","article-title":"Acute pancreatitis after long\u2010term 5\u2010aminosalicylic acid therapy","volume":"92","author":"Fernandez J","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2705-7"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199004000-00019"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2005.00881.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90703-1"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.9.1076"},{"key":"e_1_2_6_32_2","first-page":"1161","article-title":"Corticosteroid\u2010induced pancreatitis: a case report demonstrating recurrence with rechallenge","volume":"83","author":"Levine RA","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-6-891"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328133f2fb"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000173929.60115.b4"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)33395-5"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198810000-00016"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.18.2201"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04098.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1052-5157(02)00009-0"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01287.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archinte.1988.00380020041008","article-title":"Extraintestinal manifestations of idiopathic inflammatory bowel disese","volume":"148","author":"Danzi JT","year":"1988","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000094564"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2008.03746.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2008.03746.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T15:16:09Z","timestamp":1697210169000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2008.03746.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,31]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1365-2036.2008.03746.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03746.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,31]]}}}